AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RHYTHM BIOSCIENCES LTD

0.089

+0.0044.71%

Volume:296.52K

Turnover:27.33K

Market Cap:29.02M

PE:-6.26

High:0.098

Open:0.092

Low:0.086

Close:0.085

52wk High:0.210

52wk Low:0.047

Shares:326.07M

Float Shares:188.31M

Volume Ratio:0.14

T/O Rate:0.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.014

EPS(LYR):-0.014

ROE:-501.54%

ROA:-107.16%

PB:43.98

PE(LYR):-6.26

Loading ...

Overview Company News Filings

BUZZ-Australia's Rhythm Biosciences set for best day in four months on commercialisation of cancer test

BRIEF-Rhythm Biosciences Says CFO Todd Perkinson To Leave

Rhythm Biosciences - CFO Todd Perkinson to Leave

THOMSON REUTERS

Rhythm Biosciences Ltd-Departure of Chief Financial Officer

THOMSON REUTERS

BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration

BRIEF-Rhythm Biosciences Entered Collaboration With Southern Hub Research Team, Royal Surrey NHS Foundation Trust

Rhythm Biosciences Ltd - Entered a Collaboration With Southern Hub Research Team, Royal Surrey Nhs Foundation Trust

THOMSON REUTERS

Rhythm Biosciences - Collaboration to Evaluate Suitability of Colostat for Potential Use Within Bowel Cancer Screening Pathway in England

THOMSON REUTERS

BRIEF-Rhythm Biosciences Enters A Us Marketing Partnership With Catch Bio

Rhythm Biosciences Ltd - Enters a US Marketing Partnership With Catch Bio

THOMSON REUTERS

Rhythm Biosciences Says Gavin Fox-Smith Appointed Chair

BRIEF-Rhythm Biosciences Says Gavin Fox-Smith Appointed Chair

Rhythm Biosciences Ltd - Otto Buttula Retires as Chair

THOMSON REUTERS

Rhythm Biosciences Ltd-Gavin Fox-Smith Appointed Chair of Rhythm Biosciences

THOMSON REUTERS

Rhythm Biosciences Ltd-Colostat Clinical Performance Update

THOMSON REUTERS

Rhythm Biosciences Ltd-Appendix 4C and Market Update

THOMSON REUTERS

BRIEF-Rhythm Biosciences Announces Strategic Partnership With Know Your Lemons Foundation

Rhythm Biosciences to Raise AU$3.8 Million via Share Placement; Shares Rise 5%

MT Newswires Live

BRIEF-Rhythm Biosciences To Raise Up To A$3.75 Million At A$0.09 Per Share

Rhythm Biosciences Ltd - to Raise up to a$3.75 Mln at a$0.09 per Share

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RHY.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RHY.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","market":"AU","secType":"STK","nameCN":"RHYTHM BIOSCIENCES LTD","latestPrice":0.089,"timestamp":1765948320000,"preClose":0.085,"halted":0,"volume":296521,"delay":0,"nameEN":"RHYTHM BIOSCIENCES LTD","floatShares":188306561,"shares":326068419,"eps":-0.014222,"marketStatus":"Not Yet Opened","change":0.004,"latestTime":"12-17 16:12:00 AEDT","open":0.092,"high":0.098,"low":0.086,"amount":27327,"amplitude":0.141176,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.014222,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1766012400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.085,"openAndCloseTimeList":[[1765926000000,1765947600000]],"volumeRatio":0.13518012009999755,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","floatShares":188306561,"roa":"-107.16%","roe":"-501.54%","lyrEps":-0.014222,"volumeRatio":0.13518012009999755,"shares":326068419,"dividePrice":0,"high":0.098,"amplitude":0.141176,"preClose":0.085,"low":0.086,"week52Low":0.047,"pbRate":"43.98","psRate":"9.09","week52High":0.21,"institutionHeld":0,"latestPrice":0.089,"eps":-0.014222,"divideRate":0,"volume":296521,"delay":0,"ttmEps":-0.014222,"open":0.092,"prevYearClose":0.087,"prevWeekClose":0.105,"prevMonthClose":0.086,"prevQuarterClose":0.083,"fiveDayClose":0.081,"twentyDayClose":0.087,"sixtyDayClose":0.089,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RHY.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-07-27","symbol":"RHY.AU","type":"split","dateTimestamp":1595772000000,"forFactor":875,"toFactor":1000,"ratio":0.875}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RHY.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RHY.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590297875","title":"BUZZ-Australia's Rhythm Biosciences set for best day in four months on commercialisation of cancer test","url":"https://stock-news.laohu8.com/highlight/detail?id=2590297875","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590297875?lang=en_us&edition=fundamental","pubTime":"2025-12-12 11:08","pubTimestamp":1765508890,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Rhythm Biosciences set for best day in four months on commercialisation of cancer test** Shares of Australia's Rhythm Biosciences  RHY.AX jump 38.6% to A$0.115, set for best day since August 6 if gains hold ** Stock at highest since October 15 ** Cancer diagnostics tech firm commences commercialisation of its flagship blood-based colorectal cancer test - ColoSTAT** YTD shares up 32.2%   ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL6N3XI05X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2590377195","title":"BRIEF-Rhythm Biosciences Says CFO Todd Perkinson To Leave","url":"https://stock-news.laohu8.com/highlight/detail?id=2590377195","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590377195?lang=en_us&edition=fundamental","pubTime":"2025-12-10 12:13","pubTimestamp":1765340026,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Says CFO Todd Perkinson To LeaveDec 10 (Reuters) - Rhythm Biosciences Ltd RHY.AX:CFO TODD PERKINSON TO LEAVEFurther company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nTUE5V94DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2590377166","title":"Rhythm Biosciences - CFO Todd Perkinson to Leave","url":"https://stock-news.laohu8.com/highlight/detail?id=2590377166","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590377166?lang=en_us&edition=fundamental","pubTime":"2025-12-10 12:11","pubTimestamp":1765339899,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nTUE5V94DB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2590377161","title":"Rhythm Biosciences Ltd-Departure of Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2590377161","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590377161?lang=en_us&edition=fundamental","pubTime":"2025-12-10 12:11","pubTimestamp":1765339899,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nTUE5V94DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2590037422","title":"BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2590037422","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590037422?lang=en_us&edition=fundamental","pubTime":"2025-12-10 11:17","pubTimestamp":1765336642,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration** Rhythm Biosciences RHY.AX rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week** Stock hits highest since December 3** Medical diagnostics co enters collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England** ColoSTAT test is a blood-based test used to detect colorectal cancer** YTD, RHY down ~6%  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nL6N3XG05W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2590537631","title":"BRIEF-Rhythm Biosciences Entered Collaboration With Southern Hub Research Team, Royal Surrey NHS Foundation Trust","url":"https://stock-news.laohu8.com/highlight/detail?id=2590537631","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590537631?lang=en_us&edition=fundamental","pubTime":"2025-12-10 09:21","pubTimestamp":1765329686,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Entered Collaboration With Southern Hub Research Team, Royal Surrey NHS Foundation TrustDec 10  - Rhythm Biosciences Ltd RHY.AX:ENTERED A COLLABORATION WITH SOUTHERN HUB RESEARCH TEAM, ROYAL SURREY NHS FOUNDATION TRUSTCOLLABORATION TO EVALUATE SUITABILITY OF COLOSTAT FOR POTENTIAL USE WITHIN BOWEL CANCER SCREENING PATHWAY IN ENGLANDFurther company coverage: RHY.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XF0IV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2590322848","title":"Rhythm Biosciences Ltd - Entered a Collaboration With Southern Hub Research Team, Royal Surrey Nhs Foundation Trust","url":"https://stock-news.laohu8.com/highlight/detail?id=2590322848","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590322848?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:55","pubTimestamp":1765317335,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nFWN3XF0IV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2590322843","title":"Rhythm Biosciences - Collaboration to Evaluate Suitability of Colostat for Potential Use Within Bowel Cancer Screening Pathway in England","url":"https://stock-news.laohu8.com/highlight/detail?id=2590322843","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590322843?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:55","pubTimestamp":1765317335,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nFWN3XF0IV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2590603733","title":"BRIEF-Rhythm Biosciences Enters A Us Marketing Partnership With Catch Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2590603733","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590603733?lang=en_us&edition=fundamental","pubTime":"2025-12-09 09:05","pubTimestamp":1765242304,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Enters A Us Marketing Partnership With Catch BioDec 9 (Reuters) - Rhythm Biosciences Ltd RHY.AX:ENTERS A US MARKETING PARTNERSHIP WITH CATCH BIOFurther company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nFWN3XE1BG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2590136633","title":"Rhythm Biosciences Ltd - Enters a US Marketing Partnership With Catch Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2590136633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590136633?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:30","pubTimestamp":1765229421,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nFWN3XE1BG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2584488925","title":"Rhythm Biosciences Says Gavin Fox-Smith Appointed Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2584488925","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584488925?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:33","pubTimestamp":1763570020,"startTime":"0","endTime":"0","summary":"Nov 5 (Reuters) - Rhythm Biosciences Ltd ::*GAVIN FOX-SMITH APPOINTED CHAIR OF RHYTHM BIOSCIENCES*OTTO BUTTULA RETIRES AS CHAIR*Further company coverage: RHY.AX* ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSDbVf1kN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2581790473","title":"BRIEF-Rhythm Biosciences Says Gavin Fox-Smith Appointed Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2581790473","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581790473?lang=en_us&edition=fundamental","pubTime":"2025-11-05 10:04","pubTimestamp":1762308252,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Says Gavin Fox-Smith Appointed ChairNov 5 (Reuters) - Rhythm Biosciences Ltd RHY.AX:GAVIN FOX-SMITH APPOINTED CHAIR OF RHYTHM BIOSCIENCESOTTO BUTTULA RETIRES AS CHAIRFurther company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUE5DDR5F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2581790444","title":"Rhythm Biosciences Ltd - Otto Buttula Retires as Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2581790444","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581790444?lang=en_us&edition=fundamental","pubTime":"2025-11-05 10:03","pubTimestamp":1762308185,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUE5DDR5F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2581179044","title":"Rhythm Biosciences Ltd-Gavin Fox-Smith Appointed Chair of Rhythm Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2581179044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581179044?lang=en_us&edition=fundamental","pubTime":"2025-11-05 10:03","pubTimestamp":1762308185,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUE5DDR5F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2579513004","title":"Rhythm Biosciences Ltd-Colostat Clinical Performance Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2579513004","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579513004?lang=en_us&edition=fundamental","pubTime":"2025-10-30 06:34","pubTimestamp":1761777285,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUE6Y3TYK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2579913661","title":"Rhythm Biosciences Ltd-Appendix 4C and Market Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2579913661","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579913661?lang=en_us&edition=fundamental","pubTime":"2025-10-29 06:02","pubTimestamp":1761688978,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nTUEC9S80H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2562777672","title":"BRIEF-Rhythm Biosciences Announces Strategic Partnership With Know Your Lemons Foundation","url":"https://stock-news.laohu8.com/highlight/detail?id=2562777672","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562777672?lang=en_us&edition=fundamental","pubTime":"2025-08-28 09:14","pubTimestamp":1756343643,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Announces Strategic Partnership With Know Your Lemons FoundationAug 28  - Rhythm Biosciences Ltd RHY.AX:STRATEGIC PARTNERSHIP WITH KNOW YOUR LEMONS FOUNDATIONTO MAKE GENETYPE AVAILABLE ON KNOW YOUR LEMONS APPFurther company coverage: RHY.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nFWN3UJ0GI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2560979841","title":"Rhythm Biosciences to Raise AU$3.8 Million via Share Placement; Shares Rise 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560979841","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560979841?lang=en_us&edition=fundamental","pubTime":"2025-08-18 12:02","pubTimestamp":1755489748,"startTime":"0","endTime":"0","summary":"Rhythm Biosciences  received firm commitments to raise AU$3.8 million through a placement of 41.7 million new shares at AU$0.09 apiece to existing and new institutional, professional, and sophisticated investors, according to a Monday filing with the Australian bourse.The offer price is a nearly 25% discount to the stock's 15-day volume-weighted average price, the filing said.Proceeds will be used for research and development activities, commercialization of products, and working capital, the filing added.Shares of the company rose nearly 5% in recent Monday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2560214973","title":"BRIEF-Rhythm Biosciences To Raise Up To A$3.75 Million At A$0.09 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2560214973","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560214973?lang=en_us&edition=fundamental","pubTime":"2025-08-18 09:16","pubTimestamp":1755479807,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences To Raise Up To A$3.75 Million At A$0.09 Per ShareAug 18 (Reuters) - Rhythm Biosciences Ltd RHY.AX:TO RAISE UP TO A$3.75 MILLION AT A$0.09 PER SHAREFurther company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nFWN3U8099:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2560783039","title":"Rhythm Biosciences Ltd -  to Raise up to a$3.75 Mln at a$0.09 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2560783039","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560783039?lang=en_us&edition=fundamental","pubTime":"2025-08-18 07:34","pubTimestamp":1755473664,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250817:nFWN3U8099:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHY.AU","BK7124"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}]}}